167 related articles for article (PubMed ID: 33591120)
1. Opioid Prescriptions by Pain Medicine Physicians in the Medicare Part D Program: A Cross-Sectional Study.
Goel V; Moran B; Kaizer AM; Sivanesan E; Patwardhan AM; Ibrahim M; DeWeerth JC; Shannon C; Shankar H
Anesth Analg; 2021 Jun; 132(6):1748-1755. PubMed ID: 33591120
[TBL] [Abstract][Full Text] [Related]
2. Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia.
Wood SF; Podrasky J; McMonagle MA; Raveendran J; Bysshe T; Hogenmiller A; Fugh-Berman A
PLoS One; 2017; 12(10):e0186060. PubMed ID: 29069085
[TBL] [Abstract][Full Text] [Related]
3. Brand Medications and Medicare Part D: How Eye Care Providers' Prescribing Patterns Influence Costs.
Newman-Casey PA; Woodward MA; Niziol LM; Lee PP; De Lott LB
Ophthalmology; 2018 Mar; 125(3):332-339. PubMed ID: 28625684
[TBL] [Abstract][Full Text] [Related]
4. Prescription patterns and costs of acne/rosacea medications in Medicare patients vary by prescriber specialty.
Zhang M; Silverberg JI; Kaffenberger BH
J Am Acad Dermatol; 2017 Sep; 77(3):448-455.e2. PubMed ID: 28651825
[TBL] [Abstract][Full Text] [Related]
5. Factors Associated With Prescriptions for Branded Medications in the Medicare Part D Program.
Socal MP; Bai G; Anderson GF
JAMA Netw Open; 2021 Mar; 4(3):e210483. PubMed ID: 33651110
[TBL] [Abstract][Full Text] [Related]
6. Opioid Prescribing to Medicare Part D Enrollees, 2013-2017: Shifting Responsibility to Pain Management Providers.
Romman AN; Hsu CM; Chou LN; Kuo YF; Przkora R; Gupta RK; Lozada MJ
Pain Med; 2020 Nov; 21(7):1400-1407. PubMed ID: 31904839
[TBL] [Abstract][Full Text] [Related]
7. Emergency Providers' Opioid Prescribing Behaviors Among Medicare Part D Beneficiaries in North Carolina, 2013-2014: Medication Utilization and Costs.
Williams B; Mospan G; Seabock R; Gillette C; DeGeeter M
N C Med J; 2018; 79(3):143-148. PubMed ID: 29735614
[No Abstract] [Full Text] [Related]
8. Opioid prescription by gynecologic oncologists: An analysis of Medicare Part D claims.
Samuel D; Nevadunsky NS; Miller DT; Isani S; Kuo DYS; Gressel GM
Curr Probl Cancer; 2021 Apr; 45(2):100655. PubMed ID: 32994074
[TBL] [Abstract][Full Text] [Related]
9. Opioid Prescribing Patterns and Complications in the Dermatology Medicare Population.
Cao S; Karmouta R; Li DG; Din RS; Mostaghimi A
JAMA Dermatol; 2018 Mar; 154(3):317-322. PubMed ID: 29417134
[TBL] [Abstract][Full Text] [Related]
10. Opioid Prescribing by Emergency Physicians: Trends Study of Medicare Part D Prescriber Data 2013-2019.
Cai C; Knudsen S; Weant K
J Emerg Med; 2024 Mar; 66(3):e313-e322. PubMed ID: 38290881
[TBL] [Abstract][Full Text] [Related]
11. A comparison of costs of Medicare Part D prescriptions dispensed at retail and mail order pharmacies.
Carroll NV
J Manag Care Spec Pharm; 2014 Sep; 20(9):959-67. PubMed ID: 25166295
[TBL] [Abstract][Full Text] [Related]
12. Prescribing Patterns and Costs Associated with Postoperative Eye Drop Use in Medicare Beneficiaries Undergoing Cataract Surgery.
Zafar S; Wang P; Schein OD; Srikumaran D; Makary M; Woreta FA
Ophthalmology; 2020 May; 127(5):573-581. PubMed ID: 31952884
[TBL] [Abstract][Full Text] [Related]
13. Cost of pain medication to treat adult patients with nonmalignant chronic pain in the United States.
Rasu RS; Vouthy K; Crowl AN; Stegeman AE; Fikru B; Bawa WA; Knell ME
J Manag Care Spec Pharm; 2014 Sep; 20(9):921-8. PubMed ID: 25166291
[TBL] [Abstract][Full Text] [Related]
14. Are Opioids Out? Assessing Prescription Patterns in Plastic Surgery Using Medicare Part D Beneficiary Data.
Maisner RS; Song A; Zhou B; Srinivasan N; Thepmankorn P; Siniakowicz C; Ayyala HS
Ann Plast Surg; 2022 May; 88(3 Suppl 3):S266-S273. PubMed ID: 35180750
[TBL] [Abstract][Full Text] [Related]
15. Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data.
Sharma M; Vadhariya A; Johnson ML; Marcum ZA; Holmes HM
BMC Health Serv Res; 2018 Apr; 18(1):236. PubMed ID: 29609611
[TBL] [Abstract][Full Text] [Related]
16. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.
DeJong C; Aguilar T; Tseng CW; Lin GA; Boscardin WJ; Dudley RA
JAMA Intern Med; 2016 Aug; 176(8):1114-1122. PubMed ID: 27322350
[TBL] [Abstract][Full Text] [Related]
18. Opioid Prescribing Patterns of Optometrists in the Medicare Part D Database.
Dryden SC; O'Malley HA; Adams LR; Nix GC; Rho JE; Vacheron AB; Fleming JC; Fowler BT
Optom Vis Sci; 2022 Jan; 99(1):31-34. PubMed ID: 34882610
[TBL] [Abstract][Full Text] [Related]
19. Analysis of psychiatrists' prescription of opioid, benzodiazepine, and buprenorphine in Medicare Part D in the United States.
Pan K; Silver S; Davis C
Trends Psychiatry Psychother; 2020; 42(1):48-54. PubMed ID: 32321084
[TBL] [Abstract][Full Text] [Related]
20. Characterizing Opioid Prescribing Trends of Medical Oncologists From 2013 to 2019: Analysis From the Centers for Medicare & Medicaid Services Medicare Part D Prescribers Database.
Korst MR; Santos Teles M; Choudhry HS; Santitoro JG; Garcia DJ; Schwab SMT; Kra JA
JCO Oncol Pract; 2024 Feb; 20(2):268-277. PubMed ID: 38061003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
